Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30698081 | 0.98 | CA12 (0.47) | CA12CA14TSHRDPP4BIRC2 | |
| SCHEMBL2491150 | 0.86 | DPP4 (0.50) | CA12CA14TSHRDPP4BIRC2 | |
| SCHEMBL7348800 | 0.86 | DPP4 (0.50) | CA12CA14TSHRDPP4BIRC2 | |
| Hydrochloric Acid SCHEMBL7324906 | 0.84 | DPP4 (0.48) | CA12CA14TSHRDPP4BIRC2 | |
| Hydrochloric Acid SCHEMBL7321497 | 0.84 | DPP4 (0.48) | CA12CA14TSHRDPP4BIRC2 | |
| SCHEMBL10792345 | 0.83 | CA12 (0.52) | CA12CA14TSHRBIRC2SMN1; SMN2 | |
| SCHEMBL10792348 | 0.83 | CA12 (0.52) | CA12CA14TSHRBIRC2SMN1; SMN2 | |
| SCHEMBL7354071 | 0.82 | DPP4 (0.47) | CA12CA14TSHRDPP4BIRC2 | |
| SCHEMBL30698098 | 0.82 | DPP4 (0.41) | DPP4BIRC2 | |
| SCHEMBL25650702 | 0.82 | DPP4 (0.51) | CA12CA14TSHRDPP4BIRC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025283-A | Amide compound and application thereof | 成都地奥制药集团有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-119638780-A | Nitrogen-containing compound, preparation method and application thereof | 成都地奥制药集团有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119529020-A | Nitrogen-containing heterocyclic compound, and preparation method and application thereof | 成都地奥制药集团有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119504546-A | Lactam ring compounds and uses thereof | 成都地奥制药集团有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-113831391-B | Dipeptide compound capable of exerting rapid antidepressant effect and application thereof | 南京医科大学 | 2023-10-13 | — | — | CN | disclosed |
| CN-112898224-B | Allyl alcohol-supported macrolide compound and application thereof | 中国科学院上海药物研究所 | 2023-02-17 | — | — | CN | disclosed |
| US-20100261914-A1 | IAP BINDING COMPOUNDS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2010-10-14 | — | — | US | disclosed |
| US-20100261914-A1 | IAP BINDING COMPOUNDS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2010-10-14 | — | — | US | disclosed |
| CN-101235078-B | Method for generating amido bond | UNIV XIAMEN | 2010-08-25 | — | — | CN | disclosed |
| US-7718600-B2 | IAP binding compounds | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2010-05-18 | — | — | US | disclosed |
| US-7718600-B2 | IAP binding compounds | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2010-05-18 | — | — | US | disclosed |
| CN-101235078-A | Method for generating amido bond | UNIV XIAMEN (CN) | 2008-08-06 | — | — | CN | disclosed |
| US-20070032437-A1 | that bind cellular inhibitor of apoptosis proteins; drug design and development for diagnosis, prevention and treatment of cell proliferative disease; anticarcinogenic agents | THE TRUSTEES OF PRINCETON UNIVERSITY | 2007-02-08 | — | — | US | disclosed |
| US-20070032437-A1 | that bind cellular inhibitor of apoptosis proteins; drug design and development for diagnosis, prevention and treatment of cell proliferative disease; anticarcinogenic agents | THE TRUSTEES OF PRINCETON UNIVERSITY | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032437-A1 | that bind cellular inhibitor of apoptosis proteins; drug design and development for diagnosis, prevention and treatment of cell proliferative disease; anticarcinogenic agents | BIRC3, API5, BID | CA12 3086/4885CA14 2586/4885TSHR 2561/4885 |
| US-20100261914-A1 | IAP BINDING COMPOUNDS | BIRC3, BIRC5, BIRC2 | CA12 4357/4885CA14 4274/4885TSHR 3240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.